Main Line Health has adopted a new cardiac monitoring technology, created by Medtronic, Inc. The Reveal LINQ Insertable Cardiac Monitor (ICM) System is the smallest implantable cardiac monitoring device available for patients. Lankenau Medical Center has completed several implantation cases, and the other Main Line Health hospitals will be adopting this technology in the coming weeks.
“There is evidence that this new system can be an important tool in diagnosing the cause of stroke,” says Douglas Esberg, MD, Lankenau Heart Institute cardiologist. “The device is monitored remotely without the need for the patient to actively interact with the monitor—meaning they can find answers to their heart-related issues without interrupting their lifestyle. It’s also faster and easier to implant, taking about a minute, requiring only local anesthesia.”
Placed just beneath the skin through a small, minimally invasive incision of less than 1 cm in the upper left side of the chest, the Reveal LINQ ICM is often nearly invisible to the naked eye once inserted. The Reveal LINQ ICM is approximately one-third the size of a AAA battery (~1 cc), making it more than 80 percent smaller than other ICMs. While significantly smaller, the device is part of a powerful system that allows physicians to continuously and wirelessly monitor a patient's heart for up to three years.
“This technology will help our patients who are at risk for cardiac arrhythmias” says Peter R. Kowey, MD, chief, Cardiovascular Medicine, Main Line Health. “This diagnostic device expands upon our commitment of delivering life-saving services with life-changing outcomes in our region.”
In addition to its continuous and wireless monitoring capabilities, the system provides remote monitoring through the Carelink® Network. Through the Carelink Network, physicians can request notifications to alert them if their patients have had cardiac events. The Reveal LINQ ICM is indicated for patients who experience symptoms such as dizziness, palpitations, syncope (fainting) and chest pain that may suggest a cardiac arrhythmia, for patients at increased risk for cardiac arrhythmias, and to look for arrhythmias as a cause for stroke in patients when no other cause is known. The Reveal LINQ system also includes the new MyCareLink (TM) Patient Monitor, a simplified remote monitoring system with global cellular technology that transmits patients' cardiac device diagnostic data to their clinicians from nearly any location in the world.
Founded in 1985, Main Line Health (MLH) is a not-for-profit health system serving portions of Philadelphia and its western suburbs. At its core are four of the region’s respected acute care hospitals—Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital—as well as one of the nation’s premier facilities for rehabilitative medicine, Bryn Mawr Rehab Hospital; Mirmont Treatment Center for drug and alcohol recovery; and Main Line Health HomeCare & Hospice, a home health service. Main Line Health also consists of Main Line HealthCare, one of the region’s largest multi-specialty physician networks, and the Lankenau Institute for Medical Research, a non-profit biomedical research organization located on the campus of Lankenau Medical Center. Main Line Health also consists of four outpatient health centers located in Broomall, Collegeville, Exton and Newtown Square. Main Line Health hospitals, with more than 10,000 employees and 2,000 physicians, are the recipients of numerous awards for quality care and service, including recognition among Truven Health Analytics’ list of Top 100 Hospitals and top 20 percent of health systems in the nation, and Magnet®, the nation’s highest honor for nursing excellence. Main Line Health is among the area’s leaders in medicine, providing advanced patient-centered care, education and research to help our community stay healthy.
Mary Kate Coghlan
© 2014 Main Line Health